Aspiriant LLC’s Becton Dickinson BDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,330
| Closed | -$305K | – | 310 |
|
|
2025
Q1 | $305K | Buy |
1,330
+209
| +19% | +$48.5K | 0.01% | 235 |
|
|
2024
Q4 | $254K | Sell |
1,121
-50
| -4% | -$11.5K | 0.01% | 254 |
|
|
2024
Q3 | $282K | Buy |
1,171
+91
| +8% | +$21.3K | 0.01% | 241 |
|
|
2024
Q2 | $252K | Sell |
1,080
-78
| -7% | -$18.4K | 0.01% | 252 |
|
|
2024
Q1 | $287K | Sell |
1,158
-26
| -2% | -$6.22K | 0.01% | 250 |
|
|
2023
Q4 | $289K | Sell |
1,184
-15
| -1% | -$3.7K | 0.01% | 249 |
|
|
2023
Q3 | $310K | Buy |
1,199
+11
| +0.9% | +$2.97K | 0.02% | 216 |
|
|
2023
Q2 | $314K | Hold |
1,188
| – | – | 0.02% | 215 |
|
|
2023
Q1 | $294K | Hold |
1,188
| – | – | 0.02% | 221 |
|
|
2022
Q4 | $302K | Buy |
1,188
+105
| +10% | +$24.8K | 0.02% | 213 |
|
|
2022
Q3 | $241K | Sell |
1,083
-13
| -1% | -$3.23K | 0.01% | 230 |
|
|
2022
Q2 | $271K | Sell |
1,096
-64
| -6% | -$16.3K | 0.01% | 224 |
|
|
2022
Q1 | $302K | Sell |
1,160
-2
| -0.2% | -$515 | 0.02% | 224 |
|
|
2021
Q4 | $286K | Buy |
1,162
+151
| +15% | +$36.2K | 0.02% | 231 |
|
|
2021
Q3 | $242K | Buy |
1,011
+1
| +0.1% | +$245 | 0.01% | 213 |
|
|
2021
Q2 | $238K | Buy |
1,010
+11
| +1% | +$2.64K | 0.01% | 216 |
|
|
2021
Q1 | $236K | Sell |
999
-9
| -0.9% | -$2.2K | 0.02% | 189 |
|
|
2020
Q4 | $247K | Sell |
1,008
-2
| -0.2% | -$466 | 0.02% | 187 |
|
|
2020
Q3 | $230K | Buy |
1,010
+1
| +0.1% | +$246 | 0.02% | 200 |
|
|
2020
Q2 | $235K | Sell |
1,009
-135
| -12% | -$32.5K | 0.02% | 169 |
|
|
2020
Q1 | $256K | Sell |
1,144
-127
| -10% | -$31.4K | 0.03% | 166 |
|
|
2019
Q4 | $337K | Hold |
1,271
| – | – | 0.03% | 164 |
|
|
2019
Q3 | $314K | Sell |
1,271
-33
| -3% | -$8.15K | 0.03% | 173 |
|
|
2019
Q2 | $320K | Sell |
1,304
-146
| -10% | -$33.9K | 0.03% | 174 |
|
|
2019
Q1 | $352K | Sell |
1,450
-127
| -8% | -$30K | 0.03% | 169 |
|
|
2018
Q4 | $345K | Sell |
1,577
-123
| -7% | -$28.5K | 0.03% | 173 |
|
|
2018
Q3 | $432K | Buy |
1,700
+155
| +10% | +$38.2K | 0.04% | 164 |
|
|
2018
Q2 | $361K | Buy |
1,545
+50
| +3% | +$11.1K | 0.03% | 185 |
|
|
2018
Q1 | $316K | Buy |
+1,495
| New | +$327K | 0.03% | 189 |
|
|
2017
Q4 | – | Sell |
-1,534
| Closed | -$293K | – | 92 |
|
|
2017
Q3 | $293K | Buy |
1,534
+27
| +2% | +$5.24K | 0.02% | 167 |
|
|
2017
Q2 | $287K | Sell |
1,507
-480
| -24% | -$87.7K | 0.03% | 174 |
|
|
2017
Q1 | $356K | Buy |
1,987
+377
| +23% | +$65.7K | 0.03% | 165 |
|
|
2016
Q4 | $260K | Sell |
1,610
-505
| -24% | -$83.8K | 0.02% | 168 |
|
|
2016
Q3 | $371K | Buy |
+2,115
| New | +$362K | 0.04% | 153 |
|
Other funds holding BDX
Aspiriant LLC's BDX Position: Q2 2025 in Review
Aspiriant LLC sold out of Becton Dickinson (BDX) in Q2 2025, closing a stake of 1,330 shares — an estimated $305K sold.
Aspiriant LLC first reported a position in BDX in Q3 2016 and held it in 34 quarters. The position peaked at $432K in Q3 2018. 1,516 funds tracked by Wall St. Rank hold BDX as of Q2 2025.
- Aspiriant LLC reported no remaining Becton Dickinson position as of Q2 2025 after selling out during the quarter.
- Aspiriant LLC sold 1,330 Becton Dickinson shares in Q2 2025, an estimated $305K.
- Aspiriant LLC first reported a position in Becton Dickinson in Q3 2016 and held it in 34 quarters.
- Aspiriant LLC's Becton Dickinson position peaked at $432K in Q3 2018.
- 1,516 funds tracked by Wall St. Rank held Becton Dickinson as of Q2 2025.
Based on Aspiriant LLC's 13F filing for Q2 2025, filed 29 Jul 2025.